Format

Send to:

Choose Destination
See comment in PubMed Commons below
Pediatrics. 2014 Jan;133(1):164-70. doi: 10.1542/peds.2013-3444. Epub 2013 Dec 30.

Use of inhaled nitric oxide in preterm infants.

Abstract

Nitric oxide, an important signaling molecule with multiple regulatory effects throughout the body, is an important tool for the treatment of full-term and late-preterm infants with persistent pulmonary hypertension of the newborn and hypoxemic respiratory failure. Several randomized controlled trials have evaluated its role in the management of preterm infants ≤ 34 weeks' gestational age with varying results. The purpose of this clinical report is to summarize the existing evidence for the use of inhaled nitric oxide in preterm infants and provide guidance regarding its use in this population.

KEYWORDS:

bronchopulmonary dysplasia; hypoxic respiratory failure; inhaled nitric oxide; preterm infants

PMID:
24379225
[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Write to the Help Desk